TrademarkDir
OPTIGEN
LIVE

Serial Number

78340427

Owner

CANON MEDICAL DIAGNOSTICS USA, INC.

Attorney

Fara S. Sunderji

Filing Date

Dec 12, 2003

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OPTIGEN Trademark

Serial Number: 78340427 • Registration: 3197258

OPTIGEN is a trademark filed by CANON MEDICAL DIAGNOSTICS USA, INC. on December 12, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CANON MEDICAL DIAGNOSTICS USA, INC. (2 trademarks)

630 CLYDE COURT
MOUNTAIN VIEW, CA 94043-2239

Entity Type: 03

HITACHI CHEMICAL DIAGNOSTICS, INC. (4 trademarks)

630 CLYDE COURT
MOUNTAIN VIEW, CA 94043

Entity Type: 03

MINARIS MEDICAL AMERICA, INC. (4 trademarks)

630 CLYDE COURT
MOUNTAIN VIEW, CA 94043

Entity Type: 03

Trademark Details

Filing Date

December 12, 2003

Registration Date

January 9, 2007

Published for Opposition

June 14, 2005

Goods & Services

In vitro allergy panel test kits consisting primarily of diagnostic reagents and serum test devices for clinic and medical laboratory use for humans

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 16, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 16, 2026 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 9, 2026 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 24, 2025 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 28, 2021 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 7, 2017 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 7, 2017 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 7, 2017 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 7, 2017 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 5, 2016 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2016 TCCA
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 9, 2016 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 26, 2013 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 26, 2013 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 25, 2013 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 9, 2013 E815
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2007 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 28, 2006 REGV
ASSIGNED TO LIE
Nov 27, 2006 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 10, 2006 CNPR
AMENDMENT FROM APPLICANT ENTERED
Oct 26, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2006 CRFA
PAPER RECEIVED
Oct 20, 2006 MAIL
NON-FINAL ACTION E-MAILED
Apr 23, 2006 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 23, 2006 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 4, 2006 SUPC
PAPER RECEIVED
Mar 8, 2006 MAIL
USE AMENDMENT FILED
Mar 6, 2006 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2005 NOAM
PUBLISHED FOR OPPOSITION
Jun 14, 2005 PUBO
NOTICE OF PUBLICATION
May 25, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 23, 2005 PREV
ASSIGNED TO LIE
Feb 18, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Feb 10, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2005 CRFA
PAPER RECEIVED
Jan 25, 2005 MAIL
NON-FINAL ACTION MAILED
Jul 21, 2004 CNRT
NON-FINAL ACTION E-MAILED
Jul 20, 2004 GNRT
ASSIGNED TO EXAMINER
Jul 5, 2004 DOCK
NEW APPLICATION ENTERED
Jan 6, 2004 NWAP

Related Trademarks

More from this Owner

OPTIGEN

OPTIGEN

OPTIGEN

OPTIGEN

OPTIGEN

OPTIGEN

ALLOS REFERENCE LABORATORY

ALLOS REFERENCE LABORATORY

ALLOS REFERENCE LABORATORY

ALLOS REFERENCE LABORATORY

ALLOS REFERENCE LABORATORY

ALLOS REFERENCE LABORATORY